Astex Therapeutics Limited
03751674
Healthy
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/12/2025
full
Next accounts due
30/09/2027
Confirmation statement
Last: 02/05/2025
Due 16/05/2026
Industry
Officers
director · Since 01/01/2014
EVP/CHIEF STRATEGIC OFFICER
AMERICAN · USA/NEW JERSEY · Age 69
director · Since 01/03/2025
NONE
BRITISH,ITALIAN · UNITED KINGDOM · Age 69
Also on 1 other board
director · Since 01/10/2025
PRESIDENT
BRITISH · UNITED KINGDOM · Age 52
Also on 2 other boards
Persons with Significant Control
Otsuka America Inc
Suite 2020, San Francisco
Reg: 2199821 · Delaware File Number · Us Corporation
Notified 06/04/2016
Charges0 outstanding
OXFORD FINANCE CORPORATION (THE SECURITY TRUSTEE)
CAMITRO (UK) LIMITED
CompanyRankvs 63+ SIC 72110 peers75
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
that are reasonable, relevant and reliable; * state whether they have been prepared in accordance with UK-adopted international accounting standards; * assess the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and * use the going concern basis of accounting unless they either intend to liquidate the Company or to cease operations, o
Key FinancialsYear ending 31/12/2025
Net Worth
£163.6M
Balance sheet strength
Cash
—
Cash in the bank
Profit Before Tax
£331.4M
Bottom line earnings
Net Current Assets
—
Working capital
Current Assets
£177.8M
Current Liabilities
£28.7M
Cost of Sales
£54.6M
Admin Expenses
£16.7M
Operating Profit
£339.6M
Profit After Tax
£283.4M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 6.19 | +£0 |
| 2025 | 6.19 | -£36.6M |
| 2024 | 8.47 | +£64.2M |
| 2023 | — | +£47.0M |
| 2022 | — | +£15.7M |
| 2021 | 6.13 | — |
Derived from filed accounts. Not audited figures.